N01269 100 — New Brunswick, New Jersey

N01269 100 is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

N01269 100 has participated in 1 clinical trials.

Therapeutic areas: Childhood Absence Epilepsy, Juvenile Absence Epilepsy.

Sponsors: UCB Biopharma SRL.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Brunswick

Browse all research sites in New Jersey · View every site in New Brunswick

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01269 100?

N01269 100 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01269 100 conducted?

N01269 100 has 1 clinical trials on record. Their work covers Childhood Absence Epilepsy, Juvenile Absence Epilepsy.

Is N01269 100 accredited by Crixeo Clinical Trials?

N01269 100 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01269 100?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.